{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T17:31:54Z","timestamp":1783531914901,"version":"3.55.0"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","award":["2020HXBH132"],"award-info":[{"award-number":["2020HXBH132"]}],"id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2023NSFSC1892"],"award-info":[{"award-number":["2023NSFSC1892"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2024NSFSC1918"],"award-info":[{"award-number":["2024NSFSC1918"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Aspects of Medicine"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.mam.2025.101383","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T16:48:43Z","timestamp":1752598123000},"page":"101383","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Respiratory emerging viruses and drug resistance in lung cancer: challenges and new perspectives in treatment"],"prefix":"10.1016","volume":"104","author":[{"given":"Qiang","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinyin","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaili","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4969-8572","authenticated-orcid":false,"given":"Hossein","family":"Pourghadamyari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenkun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mam.2025.101383_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41568-018-0081-9","article-title":"The lung microenvironment: an important regulator of tumour growth and metastasis","volume":"19","author":"Altorki","year":"2019","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.mam.2025.101383_bib2","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.gendis.2022.02.007","article-title":"Cancer chemotherapy and beyond: current status, drug candidates, associated risks and progress in targeted therapeutics","volume":"10","author":"Anand","year":"2023","journal-title":"Genes & diseases"},{"issue":"7","key":"10.1016\/j.mam.2025.101383_bib3","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.trecan.2021.02.006","article-title":"To vaccinate or not: influenza virus and lung cancer progression","volume":"7","author":"Angrini","year":"2021","journal-title":"Trends Cancer"},{"key":"10.1016\/j.mam.2025.101383_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12964-020-0530-4","article-title":"Tumor microenvironment complexity and therapeutic implications at a glance","volume":"18","author":"Baghban","year":"2020","journal-title":"Cell Communication and Signaling"},{"issue":"5","key":"10.1016\/j.mam.2025.101383_bib5","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.coviro.2012.07.006","article-title":"The use of oncolytic viruses to overcome lung cancer drug resistance","volume":"2","author":"Beljanski","year":"2012","journal-title":"Current Opinion in Virology"},{"issue":"6","key":"10.1016\/j.mam.2025.101383_bib6","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.cell.2016.11.022","article-title":"Tumor interferon signaling regulates a multigenic resistance program to immune checkpoint blockade","volume":"167","author":"Benci","year":"2016","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.mam.2025.101383_bib7","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.cell.2019.07.019","article-title":"Opposing functions of interferon coordinate adaptive and innate immune responses to cancer immune checkpoint blockade","volume":"178","author":"Benci","year":"2019","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.mam.2025.101383_bib8","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.clim.2008.02.006","article-title":"The Src\/ABL kinase inhibitor dasatinib (BMS-354825) inhibits function of normal human T-lymphocytes in vitro","volume":"127","author":"Blake","year":"2008","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.mam.2025.101383_bib9","doi-asserted-by":"crossref","first-page":"160","DOI":"10.25259\/SNI_351_2019","article-title":"Viruses and tumor cell microenvironment: a brief summary","volume":"10","author":"Blaylock","year":"2019","journal-title":"Surg. Neurol. Int."},{"issue":"2","key":"10.1016\/j.mam.2025.101383_bib10","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ccm.2016.12.004","article-title":"Radiation pneumonitis","volume":"38","author":"Bledsoe","year":"2017","journal-title":"Clin. Chest Med."},{"issue":"15","key":"10.1016\/j.mam.2025.101383_bib11","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.3390\/cancers15153972","article-title":"Innate immune system in the context of radiation therapy for cancer","volume":"15","author":"Boopathi","year":"2023","journal-title":"Cancers"},{"issue":"Suppl. l_4","key":"10.1016\/j.mam.2025.101383_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/41.suppl_4.1","article-title":"Infection risk and cancer chemotherapy: the impact of the chemotherapeutic regimen in patients with lymphoma and solid tissue malignancies","volume":"41","author":"Bow","year":"1998","journal-title":"J. Antimicrob. Chemother."},{"issue":"4","key":"10.1016\/j.mam.2025.101383_bib13","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nri3166","article-title":"Regulating the adaptive immune response to respiratory virus infection","volume":"12","author":"Braciale","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.mam.2025.101383_bib14","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.lungcan.2018.03.005","article-title":"Canadian cancer trials group (CCTG) IND211: a randomized trial of pelareorep (Reolysin) in patients with previously treated advanced or metastatic non-small cell lung cancer receiving standard salvage therapy","volume":"120","author":"Bradbury","year":"2018","journal-title":"Lung Cancer"},{"issue":"3","key":"10.1016\/j.mam.2025.101383_bib15","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41385-019-0158-0","article-title":"Regulatory cytokine function in the respiratory tract","volume":"12","author":"Branchett","year":"2019","journal-title":"Mucosal Immunol."},{"issue":"17","key":"10.1016\/j.mam.2025.101383_bib16","doi-asserted-by":"crossref","first-page":"9394","DOI":"10.3390\/ijms22179394","article-title":"Links between infections, lung cancer, and the immune system","volume":"22","author":"Budisan","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"18","key":"10.1016\/j.mam.2025.101383_bib17","doi-asserted-by":"crossref","first-page":"5008","DOI":"10.1158\/0008-5472.CAN-13-2698","article-title":"TLR7 promotes tumor progression, chemotherapy resistance, and poor clinical outcomes in non\u2013small cell lung cancer","volume":"74","author":"Chatterjee","year":"2014","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.mam.2025.101383_bib18","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.2741\/3782","article-title":"NF-kappaB in lung cancer, a carcinogenesis mediator and a prevention and therapy target","volume":"16","author":"Chen","year":"2011","journal-title":"Front. Biosci. (Landmark Ed.)"},{"key":"10.1016\/j.mam.2025.101383_bib19","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2147\/OV.S145532","article-title":"Oncolytic virus and PD-1\/PD-L1 blockade combination therapy","author":"Chen","year":"2018","journal-title":"Oncolytic Virotherapy"},{"issue":"1","key":"10.1016\/j.mam.2025.101383_bib20","doi-asserted-by":"crossref","DOI":"10.4110\/in.2020.20.e9","article-title":"Clinical characteristics and treatment of immune-related adverse events of immune checkpoint inhibitors","volume":"20","author":"Choi","year":"2020","journal-title":"Immune network"},{"key":"10.1016\/j.mam.2025.101383_bib21","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.3389\/fphar.2019.01232","article-title":"Immunomodulatory activity of tyrosine kinase inhibitors to elicit cytotoxicity against cancer and viral infection","volume":"10","author":"Climent","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/j.mam.2025.101383_bib22","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41571-022-00639-9","article-title":"Third-generation EGFR and ALK inhibitors: mechanisms of resistance and management","volume":"19","author":"Cooper","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.mam.2025.101383_bib23","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1158\/2159-8290.CD-20-0422","article-title":"Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak","volume":"10","author":"Dai","year":"2020","journal-title":"Cancer Discov."},{"issue":"2","key":"10.1016\/j.mam.2025.101383_bib24","doi-asserted-by":"crossref","first-page":"R296","DOI":"10.1152\/ajpregu.00147.2019","article-title":"Exercise as an anti-inflammatory therapy for cancer cachexia: a focus on interleukin-6 regulation","volume":"318","author":"Daou","year":"2020","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"6","key":"10.1016\/j.mam.2025.101383_bib25","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1596006","article-title":"Oncolytic viruses: how \u201clytic\u201d must they be for therapeutic efficacy?","volume":"8","author":"Davola","year":"2019","journal-title":"OncoImmunology"},{"issue":"9","key":"10.1016\/j.mam.2025.101383_bib26","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1470-2045(05)70255-2","article-title":"Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials","volume":"6","author":"Di Maio","year":"2005","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.mam.2025.101383_bib27","series-title":"Profiling Circulating T Cells and Tumor Landscape for Predicting Responses to PD-1 Blockade in Patients with Non-small Cell Lung Cancer","author":"Dutta","year":"2024"},{"issue":"7362","key":"10.1016\/j.mam.2025.101383_bib28","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1136\/bmj.325.7362.465","article-title":"Immediate versus delayed palliative thoracic radiotherapy in patients with unresectable locally advanced non-small cell lung cancer and minimal thoracic symptoms: randomised controlled trial","volume":"325","author":"Falk","year":"2002","journal-title":"Br. Med. J."},{"issue":"5","key":"10.1016\/j.mam.2025.101383_bib29","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/08830185.2024.2333275","article-title":"Boosting immune responses in lung tumor immune microenvironment: a comprehensive review of strategies and adjuvants","volume":"43","author":"Gao","year":"2024","journal-title":"Int. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.mam.2025.101383_bib30","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1158\/2326-6066.CIR-22-0534","article-title":"Acute influenza infection promotes lung tumor growth by reprogramming the tumor microenvironment","volume":"11","author":"Garmendia","year":"2023","journal-title":"Cancer Immunol. Res."},{"issue":"4","key":"10.1016\/j.mam.2025.101383_bib31","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/s43018-020-0048-0","article-title":"EGFR inhibition triggers an adaptive response by co-opting antiviral signaling pathways in lung cancer","volume":"1","author":"Gong","year":"2020","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.mam.2025.101383_bib32","series-title":"The Tumor Microenvironment in non\u2013small-cell Lung Cancer. Seminars in Radiation Oncology","year":"2010"},{"issue":"7","key":"10.1016\/j.mam.2025.101383_bib33","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.3390\/v13071362","article-title":"The mechanism behind influenza virus cytokine storm","volume":"13","author":"Gu","year":"2021","journal-title":"Viruses"},{"issue":"8","key":"10.1016\/j.mam.2025.101383_bib34","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.3390\/cancers12082186","article-title":"SARS-CoV-2 infection and lung cancer: potential therapeutic modalities","volume":"12","author":"Gupta","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.mam.2025.101383_bib35","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.lungcan.2017.07.030","article-title":"MHC class II expression in lung cancer","volume":"112","author":"He","year":"2017","journal-title":"Lung Cancer"},{"issue":"10","key":"10.1016\/j.mam.2025.101383_bib36","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/annonc\/mdw271","article-title":"Chemotherapy remains an essential element of personalized care for persons with lung cancers","volume":"27","author":"Hellmann","year":"2016","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.mam.2025.101383_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28478","article-title":"Upregulation of PD\u2010L1 by SARS\u2010CoV\u20102 promotes immune evasion","volume":"95","author":"Huang","year":"2023","journal-title":"J. Med. Virol."},{"issue":"5","key":"10.1016\/j.mam.2025.101383_bib38","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2020.35.e31","article-title":"Involvement of the TNF-\u03b1 pathway in TKI resistance and suggestion of TNFR1 as a predictive biomarker for TKI responsiveness in clear cell renal cell carcinoma","volume":"35","author":"Hwang","year":"2020","journal-title":"J. Kor. Med. Sci."},{"issue":"10","key":"10.1016\/j.mam.2025.101383_bib39","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/s41422-019-0224-x","article-title":"Sustained type I interferon signaling as a mechanism of resistance to PD-1 blockade","volume":"29","author":"Jacquelot","year":"2019","journal-title":"Cell Res."},{"key":"10.1016\/j.mam.2025.101383_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1012806","article-title":"Immunovirotherapy: the role of antibody based therapeutics combination with oncolytic viruses","volume":"13","author":"Jafari","year":"2022","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.mam.2025.101383_bib41","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3390\/cancers11050721","article-title":"Integrins, CAFs and mechanical forces in the progression of cancer","volume":"11","author":"Jang","year":"2019","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.mam.2025.101383_bib42","doi-asserted-by":"crossref","first-page":"11127","DOI":"10.1002\/cam4.5694","article-title":"The role of viruses in cancer development versus cancer therapy: an oncological perspective","volume":"12","author":"Javid","year":"2023","journal-title":"Cancer Med."},{"issue":"8","key":"10.1016\/j.mam.2025.101383_bib43","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.4049\/jimmunol.1800671","article-title":"Influenza A virus infection causes chronic lung disease linked to sites of active viral RNA remnants","volume":"201","author":"Keeler","year":"2018","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.mam.2025.101383_bib44","first-page":"291","article-title":"SARS-CoV-2 and probable lung cancer risk","volume":"12","author":"Khiali","year":"2022","journal-title":"Bioimpacts: BI"},{"issue":"4","key":"10.1016\/j.mam.2025.101383_bib45","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022293","article-title":"TGF-\u03b21 signaling and tissue fibrosis","volume":"10","author":"Kim","year":"2018","journal-title":"Cold Spring Harbor Perspect. Biol."},{"issue":"12","key":"10.1016\/j.mam.2025.101383_bib46","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002780","article-title":"Distinct exhaustion features of T lymphocytes shape the tumor-immune microenvironment with therapeutic implication in patients with non-small-cell lung cancer","volume":"9","author":"Kim","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"4","key":"10.1016\/j.mam.2025.101383_bib47","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.celrep.2016.09.068","article-title":"Non-oncogenic acute viral infections disrupt anti-cancer responses and lead to accelerated cancer-specific host death","volume":"17","author":"Kohlhapp","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.mam.2025.101383_bib48","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.3389\/fimmu.2019.01158","article-title":"Downregulation of MHC class I expression by influenza A and B viruses","volume":"10","author":"Koutsakos","year":"2019","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.mam.2025.101383_bib49","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3390\/biomedicines12030639","article-title":"The role of cytokines and molecular pathways in lung fibrosis following SARS-CoV-2 infection: a physiopathologic (re) view","volume":"12","author":"Lazar","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.mam.2025.101383_bib50","series-title":"Unraveling Tumor Microenvironment of small-cell Lung Cancer: Implications for Immunotherapy. Seminars in Cancer Biology","year":"2022"},{"issue":"10","key":"10.1016\/j.mam.2025.101383_bib51","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1158\/1078-0432.CCR-13-2613","article-title":"Metformin sensitizes EGFR-TKI\u2013resistant human lung cancer cells in vitro and in vivo through inhibition of IL-6 signaling and EMT reversal","volume":"20","author":"Li","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mam.2025.101383_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101563","article-title":"Lung cancer and oncolytic virotherapy\u2014\u2014enemy's enemy","volume":"27","author":"Li","year":"2023","journal-title":"Transl. Oncol."},{"issue":"1","key":"10.1016\/j.mam.2025.101383_bib53","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.taap.2014.10.022","article-title":"Epithelial-mesenchymal transition and cancer stem cells, mediated by a long non-coding RNA, HOTAIR, are involved in cell malignant transformation induced by cigarette smoke extract","volume":"282","author":"Liu","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"3","key":"10.1016\/j.mam.2025.101383_bib54","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.7150\/ijbs.104079","article-title":"Revisiting of cancer immunotherapy: insight from the dialogue between glycolysis and PD-1\/PD-L1 axis in the tumor microenvironment","volume":"21","author":"Liu","year":"2025","journal-title":"Int. J. Biol. Sci."},{"issue":"10","key":"10.1016\/j.mam.2025.101383_bib55","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.annonc.2020.06.007","article-title":"COVID-19 in patients with lung cancer","volume":"31","author":"Luo","year":"2020","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.mam.2025.101383_bib56","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1007\/s11033-021-06149-8","article-title":"SARS-COV-2 infection and lung tumor microenvironment","volume":"48","author":"Malkani","year":"2021","journal-title":"Mol. Biol. Rep."},{"issue":"6","key":"10.1016\/j.mam.2025.101383_bib57","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/aps.2017.34","article-title":"Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunities","volume":"38","author":"Mangal","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"issue":"5","key":"10.1016\/j.mam.2025.101383_bib58","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1423171","article-title":"Oncolytic influenza virus infection restores immunocompetence of lung tumor-associated alveolar macrophages","volume":"7","author":"Masemann","year":"2018","journal-title":"OncoImmunology"},{"issue":"12","key":"10.1016\/j.mam.2025.101383_bib59","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1093\/jjco\/hyt189","article-title":"Five-year relative survival rate of lung cancer in the USA, Europe and Japan","volume":"43","author":"Matsuda","year":"2013","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.mam.2025.101383_bib60","series-title":"Lung Cancer and Personalized Medicine: Novel Therapies and Clinical Management","first-page":"75","article-title":"The microenvironment of lung cancer and therapeutic implications","author":"Mittal","year":"2016"},{"issue":"1","key":"10.1016\/j.mam.2025.101383_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.chstcc.2024.100126","article-title":"Managing immune checkpoint inhibitor pneumonitis in the ICU","volume":"3","author":"Montemayor","year":"2025","journal-title":"CHEST Critical Care"},{"issue":"1","key":"10.1016\/j.mam.2025.101383_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086459","article-title":"Hypoxia increases gefitinib-resistant lung cancer stem cells through the activation of insulin-like growth factor 1 receptor","volume":"9","author":"Murakami","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.mam.2025.101383_bib63","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1517\/14712590903170653","article-title":"Engineering oncolytic viruses to exploit tumor specific defects in innate immune signaling pathways","volume":"9","author":"Naik","year":"2009","journal-title":"Expet Opin. Biol. Ther."},{"issue":"1","key":"10.1016\/j.mam.2025.101383_bib64","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12964-022-00854-y","article-title":"Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons","volume":"20","author":"Naimi","year":"2022","journal-title":"Cell Commun. Signal."},{"issue":"6","key":"10.1016\/j.mam.2025.101383_bib65","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1365-2141.2005.05462.x","article-title":"Susceptibility to infection in patients with neutropenia: the role of the innate immune system","volume":"129","author":"Neth","year":"2005","journal-title":"Br. J. Haematol."},{"issue":"3","key":"10.1016\/j.mam.2025.101383_bib66","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3390\/curroncol32030121","article-title":"CD8+ CD28+ PD1\u2212 T cells as a prognostic biomarker in endometrial cancer","volume":"32","author":"Nie","year":"2025","journal-title":"Curr. Oncol."},{"issue":"1","key":"10.1016\/j.mam.2025.101383_bib67","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3390\/ijms23010146","article-title":"Matrix metalloproteinases shape the tumor microenvironment in cancer progression","volume":"23","author":"Niland","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.mam.2025.101383_bib68","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002266","article-title":"Severity of COVID-19 in patients with lung cancer: evidence and challenges","volume":"9","author":"Passaro","year":"2021","journal-title":"Journal for immunotherapy of cancer"},{"issue":"8","key":"10.1016\/j.mam.2025.101383_bib69","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1097\/JTO.0000000000000214","article-title":"Measles vaccine strains for virotherapy of non\u2013small-cell lung carcinoma","volume":"9","author":"Patel","year":"2014","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"10.1016\/j.mam.2025.101383_bib70","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The emerging hallmarks of cancer metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metab."},{"issue":"9\u201310","key":"10.1016\/j.mam.2025.101383_bib71","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.imbio.2009.06.014","article-title":"Cellular and molecular pathways linking inflammation and cancer","volume":"214","author":"Porta","year":"2009","journal-title":"Immunobiology"},{"key":"10.1016\/j.mam.2025.101383_bib72","article-title":"Understanding the impact of radiation-induced lymphopenia: preclinical and clinical research perspectives","volume":"49","author":"Prades-Sagarra","year":"2024","journal-title":"Clin. Transl. Radiat. Oncol."},{"issue":"10","key":"10.1016\/j.mam.2025.101383_bib73","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1158\/2159-8290.CD-20-0941","article-title":"Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: a COVID-19 and cancer consortium (CCC19) cohort study","volume":"10","author":"Rivera","year":"2020","journal-title":"Cancer Discov."},{"issue":"2","key":"10.1016\/j.mam.2025.101383_bib74","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jtho.2021.11.001","article-title":"Lung cancer and severe acute respiratory syndrome coronavirus 2 infection: identifying important knowledge gaps for investigation","volume":"17","author":"Rolfo","year":"2022","journal-title":"J. Thorac. Oncol."},{"issue":"8","key":"10.1016\/j.mam.2025.101383_bib75","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.3390\/ijms19082460","article-title":"TGF-\u03b2 signaling in lung health and disease","volume":"19","author":"Saito","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.mam.2025.101383_bib76","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2217\/imt-2023-0124","article-title":"Oncolytic viruses in lung cancer treatment: a review article","volume":"16","author":"Sakhi","year":"2024","journal-title":"Immunotherapy"},{"issue":"6","key":"10.1016\/j.mam.2025.101383_bib77","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3390\/biology12060843","article-title":"Involvement of matrix metalloproteinases in COVID-19: molecular targets, mechanisms, and insights for therapeutic interventions","volume":"12","author":"Salom\u00e3o","year":"2023","journal-title":"Biology"},{"issue":"9","key":"10.1016\/j.mam.2025.101383_bib78","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0308648","article-title":"Matrix metalloproteinases mediate influenza A-associated shedding of the alveolar epithelial glycocalyx","volume":"19","author":"Schaaf","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.mam.2025.101383_bib79","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3389\/fcimb.2019.00207","article-title":"The PD-1\/PD-L1 axis and virus infections: a delicate balance","volume":"9","author":"Sch\u00f6nrich","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"4","key":"10.1016\/j.mam.2025.101383_bib80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12032-025-02641-4","article-title":"Tumor microenvironment: recent advances in understanding and its role in modulating cancer therapies","volume":"42","author":"Shah","year":"2025","journal-title":"Med. Oncol."},{"key":"10.1016\/j.mam.2025.101383_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1222911","article-title":"Suppressive myeloid cells in SARS-CoV-2 and Mycobacterium tuberculosis co-infection","volume":"14","author":"Shaw","year":"2023","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.mam.2025.101383_bib82","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines12020191","article-title":"Vaccine strategies to elicit mucosal immunity","volume":"12","author":"Song","year":"2024","journal-title":"Vaccines"},{"key":"10.1016\/j.mam.2025.101383_bib83","series-title":"Handbook of Cancer and Immunology","first-page":"1","article-title":"Pro-tumorigenic and anti-tumorigenic roles of pro-inflammatory cytokines in cancer","author":"Tahmasebi","year":"2022"},{"issue":"4","key":"10.1016\/j.mam.2025.101383_bib84","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.chom.2016.09.005","article-title":"Extracellular matrix proteolysis by MT1-MMP contributes to influenza-related tissue damage and mortality","volume":"20","author":"Talmi-Frank","year":"2016","journal-title":"Cell Host Microbe"},{"issue":"6","key":"10.1016\/j.mam.2025.101383_bib85","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1200\/JCO.21.01626","article-title":"Targeted therapies for lung cancer patients with oncogenic driver molecular alterations","volume":"40","author":"Tan","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.mam.2025.101383_bib86","doi-asserted-by":"crossref","first-page":"e434","DOI":"10.1016\/j.clon.2023.04.003","article-title":"Prediction of radiation-induced lymphopenia following exposure of the thoracic region and associated risk of infections and mortality","volume":"35","author":"Terrones-Campos","year":"2023","journal-title":"Clin. Oncol."},{"issue":"8","key":"10.1016\/j.mam.2025.101383_bib87","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3390\/cancers10080248","article-title":"Lung cancers: molecular characterization, clonal heterogeneity and evolution, and cancer stem cells","volume":"10","author":"Testa","year":"2018","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.mam.2025.101383_bib88","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jtho.2020.02.010","article-title":"Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer","volume":"15","author":"Tian","year":"2020","journal-title":"J. Thorac. Oncol."},{"issue":"5","key":"10.1016\/j.mam.2025.101383_bib89","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.ccell.2020.10.002","article-title":"Supporting clinical decision-making during the SARS-CoV-2 pandemic through a global research commitment: the TERAVOLT experience","volume":"38","author":"Trama","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.mam.2025.101383_bib90","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.radonc.2021.01.034","article-title":"Risk and impact of radiation related lymphopenia in lung cancer: a systematic review and meta-analysis","volume":"157","author":"Upadhyay","year":"2021","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.mam.2025.101383_bib91","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.critrevonc.2018.01.003","article-title":"A systematic review of the influence of radiation-induced lymphopenia on survival outcomes in solid tumors","volume":"123","author":"Venkatesulu","year":"2018","journal-title":"Crit. Rev. Oncol.-Hematol."},{"issue":"10","key":"10.1016\/j.mam.2025.101383_bib92","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/S1470-2045(08)70255-9","article-title":"Lung infections after cancer chemotherapy","volume":"9","author":"Vento","year":"2008","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.mam.2025.101383_bib93","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.869768","article-title":"PD-1 immune checkpoint blockade and PSGL-1 inhibition synergize to reinvigorate exhausted T cells","volume":"13","author":"Viramontes","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mam.2025.101383_bib94","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.782852","article-title":"Antiviral responses in cancer: boosting antitumor immunity through activation of interferon pathway in the tumor microenvironment","volume":"12","author":"Vitiello","year":"2021","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.mam.2025.101383_bib95","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.3390\/ijms25021180","article-title":"Oncolytic virotherapy: a new paradigm in cancer immunotherapy","volume":"25","author":"Volovat","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.mam.2025.101383_bib96","doi-asserted-by":"crossref","first-page":"973","DOI":"10.3390\/v16060973","article-title":"The immune system\u2014A double-edged sword for adenovirus-based therapies","volume":"16","author":"Wallace","year":"2024","journal-title":"Viruses"},{"issue":"8","key":"10.1016\/j.mam.2025.101383_bib97","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1513\/pats.200809-100TH","article-title":"Smoking and lung cancer: the role of inflammation","volume":"5","author":"Walser","year":"2008","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/j.mam.2025.101383_bib98","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijid.2019.07.030","article-title":"Association between the risk of lung cancer and influenza: a population-based nested case-control study","volume":"88","author":"Weng","year":"2019","journal-title":"Int. J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.mam.2025.101383_bib99","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.ccell.2020.05.008","article-title":"TERAVOLT: thoracic cancers international COVID-19 collaboration","volume":"37","author":"Whisenant","year":"2020","journal-title":"Cancer Cell"},{"issue":"45","key":"10.1016\/j.mam.2025.101383_bib100","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1038\/onc.2008.271","article-title":"The tumor microenvironment and its role in promoting tumor growth","volume":"27","author":"Whiteside","year":"2008","journal-title":"Oncogene"},{"issue":"2\u20133","key":"10.1016\/j.mam.2025.101383_bib101","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cytogfr.2010.02.014","article-title":"Impact of tumor microenvironment on oncolytic viral therapy","volume":"21","author":"Wojton","year":"2010","journal-title":"Cytokine Growth Factor Rev."},{"issue":"6","key":"10.1016\/j.mam.2025.101383_bib102","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.14336\/AD.2022.0407","article-title":"Tumor immune microenvironment and immunotherapy in non-small cell lung cancer: update and new challenges","volume":"13","author":"Xing","year":"2022","journal-title":"Aging and disease"},{"issue":"1","key":"10.1016\/j.mam.2025.101383_bib103","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1080\/22221751.2021.1884503","article-title":"COVID-19-associated cytokine storm syndrome and diagnostic principles: an old and new issue","volume":"10","author":"Yongzhi","year":"2021","journal-title":"Emerg. Microb. Infect."},{"issue":"3","key":"10.1016\/j.mam.2025.101383_bib104","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.3390\/jcm12031098","article-title":"Talimogene laherparepvec (T-VEC): a review of the recent advances in cancer therapy","volume":"12","author":"Zhang","year":"2023","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.mam.2025.101383_bib105","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.pccm.2024.08.002","article-title":"Overcoming EGFR-TKI resistance by targeting the tumor microenvironment","volume":"2","author":"Zhang","year":"2024","journal-title":"Chin Med J Pulm Crit Care Med"},{"issue":"2","key":"10.1016\/j.mam.2025.101383_bib106","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1089\/hum.2018.055","article-title":"Oncolytic adenovirus rAd. DCN inhibits breast tumor growth and lung metastasis in an immune-competent orthotopic xenograft model","volume":"30","author":"Zhao","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.mam.2025.101383_bib107","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ijid.2020.04.086","article-title":"Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a systemic review and meta-analysis","volume":"96","author":"Zhao","year":"2020","journal-title":"Int. J. Infect. Dis."},{"issue":"31","key":"10.1016\/j.mam.2025.101383_bib108","doi-asserted-by":"crossref","first-page":"6765","DOI":"10.1039\/D0TB00649A","article-title":"Overcoming the biological barriers in the tumor microenvironment for improving drug delivery and efficacy","volume":"8","author":"Zhou","year":"2020","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.mam.2025.101383_bib109","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.3389\/fonc.2019.01044","article-title":"EMT-mediated acquired EGFR-TKI resistance in NSCLC: mechanisms and strategies","volume":"9","author":"Zhu","year":"2019","journal-title":"Front. Oncol."}],"container-title":["Molecular Aspects of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299725000470?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299725000470?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T20:07:49Z","timestamp":1772741269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0098299725000470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":109,"alternative-id":["S0098299725000470"],"URL":"https:\/\/doi.org\/10.1016\/j.mam.2025.101383","relation":{},"ISSN":["0098-2997"],"issn-type":[{"value":"0098-2997","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Respiratory emerging viruses and drug resistance in lung cancer: challenges and new perspectives in treatment","name":"articletitle","label":"Article Title"},{"value":"Molecular Aspects of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mam.2025.101383","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101383"}}